Crispr Therapeutics shares owned by Asset Management Corp
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Asset Management Corp
from 13F filings
Historical chart of Asset Management Corp investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Asset Management Corp consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Asset Management Corp
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-03-31 | $343k | 7.6k | 45.23 |
| 2022-12-31 | $425k | 11k | 40.65 |
| 2022-09-30 | $989k | 15k | 65.35 |
| 2022-06-30 | $975k | 16k | 60.79 |
| 2022-03-31 | $1.1M | 17k | 62.75 |
| 2021-12-31 | $2.2M | 29k | 75.82 |
| 2021-09-30 | $3.2M | 29k | 111.91 |
| 2021-06-30 | $1.6M | 9.7k | 161.87 |
| 2021-03-31 | $1.3M | 11k | 121.89 |
| 2020-12-31 | $590k | 3.0k | 200.00 |
| 2020-09-30 | $247k | 3.0k | 83.73 |